Consistent with this, SSc patients with elevated serum galectin-9 levels tended to have the diffuse cutaneous subtype and vital organ involvement more frequently than those with normal serum galectin-9 levels, although the differences were not statistically significant. Here, LGALS9 is linked to systemic sclerosis.